Key Takeaways
- The company reduced its yearly dividend by 50%, dropping from $1.40 to $0.70 per share
- Fiscal 2027 earnings per share outlook of $1.40–$1.50 fell short of the $1.59 analyst consensus
- A massive $2 billion impairment resulted in a quarterly net loss of $1.6 billion
- The firm anticipates organic net sales to drop 1%–3% in FY2027, a deeper decline than FY2026’s 0.4% decrease
- Shares traded down approximately 4%–5.5% in early morning sessions and have declined roughly 18% year-to-date
Conagra Brands (CAG) unveiled its fourth-quarter and full-year fiscal 2026 earnings on Wednesday, triggering a negative market response. The stock tumbled around 5.5% during premarket hours to $13.37, hovering near the bottom of its 52-week trading range between $12.53 and $20.32.
At first glance, the quarterly performance appeared solid. The company delivered adjusted earnings per share of $0.47, exceeding forecasts by one cent. Revenue reached $2.88 billion, slightly missing the $2.89 billion consensus estimate. However, these figures weren’t the focus of investor concern.
The most jarring announcement was the dramatic dividend reduction. The packaged foods company cut its annual shareholder payout by half, dropping from $1.40 to $0.70 per share. This marked a significant departure from the company’s 51-year streak of consistent dividend payments.
CEO John Brase, who assumed leadership in June, characterized the decision as a strategic recalibration. The reduction is anticipated to unlock approximately $335 million in yearly cash flow, which the company plans to allocate toward reducing debt obligations and funding capital projects.
Disappointing Forward Outlook Pressures Shares
The fiscal 2027 projections compounded investor concerns. Conagra issued adjusted EPS guidance ranging from $1.40 to $1.50, significantly below the Street’s $1.59 expectation. The company forecasts organic net sales to contract between 1% and 3%, representing a sharper downturn compared to fiscal 2026’s 0.4% decline.
Adjusted operating margin is projected to narrow further to 10.0%–10.5%, down from 11.3% in the prior fiscal year. The corporation faces inflationary headwinds of 5–6%, including tariff-related cost increases affecting beef, steel, and aluminum used in product packaging.
The opening quarter of fiscal 2027 is anticipated to present the most significant challenges, with low-single-digit organic revenue declines and adjusted operating margins in the high-single-digit range. Approximately $40 million in tariff-related expenses are concentrated in the first quarter.
The company projects its net leverage ratio at roughly 4.0x for the full year before gradually reducing it toward the 3.0x objective in subsequent periods.
Major Impairment Charge and Company Transformation
The food manufacturer recorded a $2 billion impairment charge during the quarter, attributed to the sustained decline in its share price and overall market capitalization. This write-down resulted in a net loss of $1.6 billion for the fourth quarter.
For the complete fiscal year 2026, adjusted earnings per share totaled $1.72, representing a 25.2% year-over-year decrease, though remaining within the company’s initial guidance parameters. Free cash flow conversion reached a robust 119%, despite absolute free cash flow declining 24.9% to $979 million.
Brase articulated four core strategic objectives: stabilizing profit margins, enhancing brand marketing investment, streamlining the product portfolio, and restructuring capital deployment. The company plans to increase advertising and promotional expenditures to approximately 3% of net sales in fiscal 2027, marking a 14% year-over-year increase.
Capital investment is targeted at around $550 million for fiscal 2027, up from $423 million in the previous year, with emphasis on modernizing supply chain infrastructure.
Intense competition from private-label products continues to impact sales volumes. Management acknowledged that inflation-weary consumers, particularly those affected by rising fuel costs, have been shifting toward lower-priced alternatives.
CAG stock has surrendered approximately 18% of its value since the beginning of 2026.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
